WASHINGTON – Omnicare Inc., a subsidiary of CVS Health and a leading provider of pharmacy services to long-term care facilities, has agreed to pay the United States a $15.3 million civil penalty to resolve allegations that it violated federal law by allowing opioids and other controlled substances to be dispensed...

PORTLAND, Ore.—Omnicare Inc., a subsidiary of CVS Health and a provider of pharmacy services to long-term care facilities, has agreed to pay the United States a $15.3 million civil penalty to resolve allegations that it violated federal law by, among other things, allowing opioids and other controlled substances to be...

MILWAUKEE - DEA Assistant Special Agent in Charge Paul E. Maxwell and United States Attorney Matthew D. Krueger announced today that Dr. Mehran Heydarpour of Brookfield, Wisconsin, agreed to pay $175,000 to resolve allegations that he prescribed opioid pain medications in violation of the Controlled Substances Act and that he...

ST. LOUIS – Angela K. Williams, M.D., 34, of Brentwood, Missouri, pleaded guilty today to one felony charge of fraudulently obtaining oxycodone, a narcotic opioid prescription drug. This case was investigated by the Drug Enforcement Administration St. Louis Division, the Florissant Police Department, the Town and Country Police Department, and...

URBANA, Ill. – U.S. District Judge Michael M. Mihm today sentenced a Champaign, ll., man, Stephan Caamano, to 13 years in federal prison for trafficking at least 4.3 million counterfeit Xanax pills throughout the country and laundering the proceeds. Caamano has been ordered to pay more than $2.1 million he...

NEW YORK – The United States Attorney for the Southern District of New York, Geoffrey S. Berman, the Drug Enforcement Administration Special Agent in Charge of the New York Division, Raymond P. Donovan, Special Agent in Charge of the New York Office of Homeland Security Investigations, Peter C. Fitzhugh, Superintendent...

HONOLULU – The United States Drug Enforcement Administration in Honolulu urges its DEA-registered practitioners to be cautious of telephone calls from criminals posing as DEA agents or other law enforcement personnel demanding the practitioner provide their DEA-registrant number and other practitioner-related sensitive information over the telephone. Most recently, the DEA...

LOUISVILLE, Ky. - The United States Drug Enforcement Administration today announced that it will be hosting a regional Practitioner Diversion Awareness Conference (PDAC) on March 27, 2019. The PDAC is designed to educate and assist doctors, veterinarians, dentists, physician assistants, and nurse practitioners across the Commonwealth of Kentucky in identifying...

MEDIA ADVISORY DEA ANNOUNCES 5,456 DRUG-RELATED OVERDOSE DEATHS IN PENNSYLVANIA IN 2017 Contact: Supervisory Special Agent Patrick J. Trainor, Public Information Officer, (215) 852-8740 (PHILADELPHIA) – Jon Wilson, Special Agent in Charge of the Drug Enforcement Administration’s (DEA) Philadelphia Division, announced today that 5,456 drug-related overdose deaths [1] were reported...

PHOENIX - The DEA is alerting all law enforcement, first responders and citizens to the confirmed overdose fatality attributed to the very potent and highly dangerous drug, carfentanil. A review of overdose investigation records provided to DEA’s Heroin Enforcement Action (HEAT) revealed the incident occurred in late 2017. Carfentanil is...